Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. Issue 10 (30th August 2020)

• Record Type: Journal Article
• Authors: Schulz, Martin; Griese‐Mammen, Nina; Schumacher, Pia M.; Strauch, Dorothea; Freudewald, Leonard; Said, André; Tsuyuki, Ross T.; Laufs, Ulrich; Kintscher, Ulrich; Böhm, Michael; Mahfoud, Felix
• Is Part Of: Journal of clinical hypertension. Volume 22:Issue 10(2020)
• Page Start: 1807
• Page End: 1816
• Publication Date: 2020-08-30
• Subjects: blood pressure control -- community pharmacy service -- guidelines -- hypertension -- screening; Hypertension -- Periodicals; 616.132
• DOI: 10.1111/jch.14020
• Languages: English
• ISSNs: 1524-6175

Abstract

Abstract: Involvement of community pharmacists in the detection and control of hypertension improves patient care. However, current European or North‐American guidelines do not provide specific guidance how to implement collaboration between pharmacists and physicians, especially when and how to refer patients with undetected or uncontrolled hypertension to a physician. The German Society of Cardiology and the ABDA – Federal Union of German Associations of Pharmacists developed and tested referral recommendations for community pharmacists, embedded in two guideline worksheets. The project included a guideline‐directed blood pressure (BP) measurement and recommendations when patients should be referred to their physician. A "red flag" referral within 4 weeks was recommended when SBP was >140 mm Hg or DBP >90 mm Hg (for subjects <80 years), and >160 mm Hg or >90 mm Hg (≥80 years) in undetected individuals, or >130 mm Hg or >80 mm Hg (<65 years) and >140 mm Hg or >80 mm Hg (≥65 years) in treated patients. BP was measured in 187 individuals (86 with known hypertension, mean [±SD] age 62 ± 15 years, 64% female, and 101 without known hypertension, 47 ± 16 years, 75% female) from 17 community pharmacies. In patients with hypertension, poorly controlled BP was detected in 55% (n = 47) and were referred. A total of 16/101 subjects without a history of hypertension were referred to their physician because of uncontrolled BP. Structured BP testing in pharmacies identified a significant number of subjects with undetected/undiagnosed hypertension and patients with poorly controlled BP. Community pharmacists could play a significant role in collaboration with physicians to improve the management of hypertension.